Lineage, Inc. (LINE)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy
Lineage Cell Therapeutics' OpRegen is partnered with Genentech/Roche. In my view, this is their main value driver in GA dry AMD. Looking ahead, their GAlette Phase 2a trial is enrolling, which could further validate the rest of their portfolio's potential. LCTX's pipeline also has OPC1 for spinal cord injury. Its preclinical R&D includes ANP1, PNC1, RND1, and ILT1.
Lineage, Inc. (LINE) Q3 2025 Earnings Call Transcript
Lineage, Inc. ( LINE ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Ki Bin Kim W. Lehmkuhl - CEO, President & Director Robert Crisci - Chief Financial Officer Conference Call Participants Caitlin Burrows - Goldman Sachs Group, Inc., Research Division Michael Goldsmith - UBS Investment Bank, Research Division Steve Sakwa - Evercore ISI Institutional Equities, Research Division Craig Mailman - Citigroup Inc., Research Division Ronald Kamdem - Morgan Stanley, Research Division Michael Carroll - RBC Capital Markets, Research Division Alexander Goldfarb - Piper Sandler & Co., Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Greg McGinniss - Scotiabank Global Banking and Markets, Research Division Daniel Guglielmo - Capital One Securities, Inc., Research Division Vikram Malhotra - Mizuho Securities USA LLC, Research Division Blaine Heck - Wells Fargo Securities, LLC, Research Division Michael Lewis Samir Khanal - BofA Securities, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Todd Thomas - KeyBanc Capital Markets Inc., Research Division Nicholas Thillman - Robert W.
Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Lineage, Inc. (LINE) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ethic Inc. Acquires New Holdings in Lineage, Inc. $LINE
Ethic Inc. bought a new position in shares of Lineage, Inc. (NASDAQ: LINE) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 9,151 shares of the company's stock, valued at approximately $403,000. Several other institutional investors and hedge
Lineage: Leading Cold-Storage REIT Trading At Fire-Sale Prices
Lineage, the largest temperature-controlled warehouse REIT, is trading near all-time lows since 2024's IPO due to industry headwinds and recent guidance cuts. LINE maintains a solid 5.3% dividend yield with a sustainable payout ratio that could soon increase, and continues to invest in growth through partnerships and acquisitions. The stock trades at a significant discount to NAV, offering potential upside if occupancy rates improve and macroeconomic conditions become more favorable.
Lineage: A Deeply Discounted Cold Storage Giant Positioned To Consolidate The Industry
Lineage (LINE), the world's largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry consolidation, benefiting from global scale, high margins, and a strong competitive moat. Despite challenges like oversupply and cost inflation, LINE's valuation near book value and a 5.6% dividend yield create an attractive risk/reward setup.
Lineage: Cold Storage And A 5.2% Dividend Yield
Lineage has dipped by nearly 60% over the last one year, due to a perfect storm of headwinds for the temperature-controlled warehouse owner and operator. The REIT is paying out a 5.2% dividend yield that was 154% covered by AFFO for the second quarter. An investment-grade rating at "BBB+" by Fitch Ratings and a lowered 12.2x multiple to the midpoint of its 2025 AFFO guidance range have brought me to the bull camp.
Lineage, Inc. (LINE) Q2 2025 Earnings Call Transcript
Lineage, Inc. (NASDAQ:LINE ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants R. Evan Barbosa - Vice President of Investor Relations Robert C.
Lineage, Inc. (LINE) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Lineage, Inc. (LINE) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Lineage, Inc. (LINE) Surpasses Q2 FFO and Revenue Estimates
Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.81 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to FFO of $0.84 per share a year ago.
Americold Realty Vs. Lineage: It's A Cold World
Cold storage is a complex, capital-intensive real estate niche with strong long-term demand, but recent oversupply and market headwinds have pressured REIT valuations. COLD and LINE are the two largest cold storage REITs, with COLD offering a more traditional, conservative business model and LINE focusing on tech-driven, aggressive growth. Despite both facing industry challenges, COLD's established portfolio, conservative expansion, and higher dividend yield make it more appealing compared to LINE's premium valuation and riskier strategy.
Sahara desert, once lush and green, was home to mysterious human lineage
The Sahara Desert is one of Earth's most arid and desolate places, stretching across a swathe of North Africa that spans parts of 11 countries and covers an area comparable to China or the United States. But it has not always been so inhospitable.
